pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Obesity · news · pharmadog
← back to Obesity
News mentioning Obesity
737
stories
Jul 14, 26
STAT+: Akero team, backed by Fairmount, launches new immunology company
stat
Jul 14, 26
Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctor
stat
Jul 14, 26
12 ideas for tackling the U.S. alcohol epidemic
stat
Jul 13, 26
Opinion: The shortage of forensic pathologists is hurting justice, public health, and families
stat
Jul 13, 26
Opinion: Is there a doctor on board? Yes, and airlines depend on it
stat
Jul 10, 26
US biotechs turn secretive as they fear competition from rising Chinese industry
endpoints
Jul 10, 26
STAT+: Roche ends Huntington’s gene-silencing programs
stat
Jul 10, 26
Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustments
endpoints
Jul 10, 26
Opinion: The primary care crisis paradox
stat
Jul 9, 26
Whistleblower takes on health insurance and FDA commissioner candidates
stat
Jul 9, 26
Eli Lilly dominates first-half biotech acquisitions, with no sign of slowing down
endpoints
Jul 9, 26
Who’s going to run the FDA?
stat
Jul 9, 26
Opinion: Your grandparents are using cannabis. Doctors can help them do it safely
stat
Jul 9, 26
Opinion: Who benefits from classifying obesity as a disease?
stat
Jul 8, 26
Biohaven looks to take on Lilly in the muscle-sparing obesity space
endpoints
Jul 8, 26
STAT+: Europe will accelerate its review of RevMed’s drug
stat
Jul 8, 26
Are glucose monitors a good thing for 2-year-olds? Experts look at risks, benefits
stat
Jul 7, 26
Kailera says obesity pill succeeds in late-stage trial in China
biopharma dive
Jul 7, 26
Hengrui, Kailera's GLP-1 pill posts encouraging efficacy but high side effect rates in late-stage China trials
endpoints
Jul 7, 26
STAT+: Compass says depression drug has long-lasting benefits
stat
Jul 7, 26
STAT+: Pharmalittle: We’re reading about a $10 billion Vertex deal, the pace of FDA drug approvals, and more
stat
Jul 6, 26
STAT+: Online GLP-1 prescriptions are often fast, easy — and low on clinical oversight
stat
Jul 6, 26
Cancer, immune drugmakers dominate VC funding so far in 2026
biopharma dive
Jul 2, 26
STAT+: Medicare takes another swing at 340B cuts to hospitals
stat
Jul 2, 26
STAT+: Elevance sues government over $115 million tied to Medicare Advantage star ratings
stat
Jul 2, 26
STAT+: Pharmalittle: We’re reading about a court win for Amgen, Novo seeking supplier discounts, and more
stat
Jul 2, 26
STAT+: More frequent, more intense, and longer heat waves pose health risks for Americans
stat
Jul 2, 26
BrightGene looks to the West as obesity shot nears China approval
endpoints
Jul 2, 26
The new presidential fitness test is a positive step, not the solution, experts say
stat
Jul 1, 26
Statins and blood pressure drugs changing health risks of obesity, study suggests
stat
← prev
page 18 of 25
next →